A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study examines the efficacy of the medication D-Cycloserine in the reduction of
obsessions and compulsions in individuals with obsessive-compulsive disorder (OCD). All study
participants will receive Exposure and Response Prevention, a common form of behavior therapy
for individuals with OCD. Half (50%) of the participants will be randomly assigned to the
placebo condition and the other half (50%) will be randomly assigned to receive
D-Cycloserine. Because all participants will receive 10 sessions of behavior therapy, all
participants are expected to improve from this treatment.